| pubmed-article:18804848 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18804848 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18804848 | lifeskim:mentions | umls-concept:C0035222 | lld:lifeskim |
| pubmed-article:18804848 | lifeskim:mentions | umls-concept:C0030190 | lld:lifeskim |
| pubmed-article:18804848 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18804848 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:18804848 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18804848 | pubmed:dateCreated | 2009-3-31 | lld:pubmed |
| pubmed-article:18804848 | pubmed:abstractText | Increased levels of plasminogen activator inhibitor-1 (PAI-1) have been associated with worse outcome in ALI/ARDS. A single guanosine insertion/deletion (4G/5G) polymorphism in the promoter region of the PAI-1 gene, may play an important role in the regulation of PAI-1 expression. The objective of the study was to evaluate the effect of this polymorphism on the outcome of critically ill patients with ALI/ARDS. | lld:pubmed |
| pubmed-article:18804848 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18804848 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18804848 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18804848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18804848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18804848 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18804848 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18804848 | pubmed:issn | 0049-3848 | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:DimopoulouIoa... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:OrfanosStylia... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:BonovasStefan... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:LignosMichali... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:KopteridesPet... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:ArmaganidisAp... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:TravlouAnthiA | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:TsangarisIrak... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:RaptiEvdoxiaE | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:GialerakiArgi... | lld:pubmed |
| pubmed-article:18804848 | pubmed:author | pubmed-author:TsantesArgiri... | lld:pubmed |
| pubmed-article:18804848 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18804848 | pubmed:volume | 123 | lld:pubmed |
| pubmed-article:18804848 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18804848 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18804848 | pubmed:pagination | 832-6 | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:meshHeading | pubmed-meshheading:18804848... | lld:pubmed |
| pubmed-article:18804848 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18804848 | pubmed:articleTitle | The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. | lld:pubmed |
| pubmed-article:18804848 | pubmed:affiliation | 2nd Department of Critical Care Medicine, Attikon Hospital, Medical School, University of Athens, Athens, Greece. itsagkaris@med.uoa.gr | lld:pubmed |
| pubmed-article:18804848 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:5054 | entrezgene:pubmed | pubmed-article:18804848 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18804848 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18804848 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18804848 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18804848 | lld:pubmed |
